$3.05
-0.09-2.87%
At close: Nov 13, 4:00 PM EST
$3.11
0.06112%
After Hours: 4:26 PM EST
Galectin Therapeutics Inc
GALTNASDAQ
Galectin Therapeutics (GALT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.14 | $-0.09 | -55.6 % |
| Q1 | May 15, 2026 | $-0.08 | $-0.06 | -33.3 % |
| Q4 | Mar 31, 2026 | $-0.08 | $-0.10 | 20.0 % |
| Q3 | Nov 14, 2025 | $-0.13 | $-0.11 | -18.2 % |
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.06 | $-0.10 | $-0.11 |
| Actual | $-0.14 | $-0.08 | $-0.08 | $-0.13 |
| Surprise | -55.6% | -33.3% | +20.0% | -18.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.05 | $-0.05 |
| Revenue | ||
| Consensus | — | — |
